A phase II trial of Xeloda and oxaliplatin (XELOX) neo-adjuvant chemotherapy followed by surgery for advanced gastric cancer patients with para-aortic lymph node metastasis
Crossref DOI link: https://doi.org/10.1007/s00280-014-2449-1
Published Online: 2014-04-21
Published Print: 2014-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Yan
Yu, Yi-yi
Li, Wei
Feng, Yi
Hou, Jun
Ji, Yuan
Sun, Yi-hong
Shen, Kun-tang
Shen, Zhen-bin
Qin, Xin-yu
Liu, Tian-shu
License valid from 2014-04-21